Clinical Trial Update: Efficacy and Safety of MOX/ALB Co-administration [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of co-administered MOX and ALB for parasitic worm infections; completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascariasis
• Hookworm Infections
• Trichuriasis

Drugs mentioned

• ALB
• MOX

Snippet

Sponsor: Jennifer Keiser | Conditions: Trichuriasis, Ascariasis | Phase 3 | Status: COMPLETED | Results posted: 2023-02-02